Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths
- PMID: 31135726
- PMCID: PMC6548332
- DOI: 10.1097/AOG.0000000000003279
Pregnancy-Associated Death in Utah: Contribution of Drug-Induced Deaths
Abstract
Objective: Drug-induced deaths, defined as intentional or unintentional consumption of illicit substances or diverted medications leading to death, are the leading cause of death for reproductive-age women in the United States. Our objective was to describe pregnancy-associated deaths attributed to drug-induced causes to identify opportunities for intervention.
Methods: Using the Utah Perinatal Morality Review Committee database, we performed a retrospective cohort study of all pregnancy-associated deaths-death of a woman during pregnancy or within 1 year from the end of pregnancy-from 2005 to 2014. We performed a detailed descriptive analysis of women with drug-induced deaths. We compared characteristics of women with drug-induced and other pregnancy-associated deaths.
Results: From 2005 to 2014, 136 pregnancy-associated deaths were identified. Drug-induced death was the leading cause of pregnancy-associated death (n=35, 26%) and 89% occurred in the postpartum period. More specifically, those with a drug-induced death were more likely to die in the late postpartum period, defined as death occurring within 43 days to 1 year of the end of the pregnancy, (n=28/35, 80%) compared with women whose deaths were from other pregnancy-associated causes (n=34/101, 34%) (P<.001). The majority of drug-induced deaths were attributed to opioids (n=27/35, 77%), prescription opioids (n=21/35, 60%), and polysubstance use (n=29/35, 83%). From 2005 to 2014, the pregnancy-associated mortality ratio increased 76%, from 23.3 in 2005 to 41.0 in 2014. During this same time period, the drug-induced pregnancy-associated mortality ratio increased 200%, from 3.9 in 2005 to 11.7 in 2014.
Conclusion: Drug-induced death is the leading cause of pregnancy-associated death in Utah and occurs primarily in the late postpartum period. Interventional studies focused on identifying and treating women at risk of drug-induced death are urgently needed.
Conflict of interest statement
Financial Disclosure
The authors did not report any potential conflicts of interest.
Figures
Similar articles
-
Enhanced surveillance for pregnancy-associated mortality--Maryland, 1993-1998.JAMA. 2001 Mar 21;285(11):1455-9. doi: 10.1001/jama.285.11.1455. JAMA. 2001. PMID: 11255421
-
Standardized Criteria for Review of Perinatal Suicides and Accidental Drug-Related Deaths.Obstet Gynecol. 2020 Oct;136(4):645-653. doi: 10.1097/AOG.0000000000003988. Obstet Gynecol. 2020. PMID: 32925616 Free PMC article.
-
Contributions of prescribed and non-prescribed opioids to opioid related deaths: population based cohort study in Ontario, Canada.BMJ. 2018 Aug 29;362:k3207. doi: 10.1136/bmj.k3207. BMJ. 2018. PMID: 30158106 Free PMC article.
-
Maternal self-harm deaths: an unrecognized and preventable outcome.Am J Obstet Gynecol. 2019 Oct;221(4):295-303. doi: 10.1016/j.ajog.2019.02.056. Epub 2019 Mar 5. Am J Obstet Gynecol. 2019. PMID: 30849358 Review.
-
Studying adverse events related to prescription opioids: the Utah experience.Pain Med. 2011 Jun;12 Suppl 2:S16-25. doi: 10.1111/j.1526-4637.2011.01133.x. Pain Med. 2011. PMID: 21668753 Review.
Cited by 21 articles
-
An Integrated Mechanistic Model of Mindfulness-Oriented Recovery Enhancement for Opioid-Exposed Mother-Infant Dyads.Front Psychol. 2021 Oct 28;12:688359. doi: 10.3389/fpsyg.2021.688359. eCollection 2021. Front Psychol. 2021. PMID: 34777086 Free PMC article. Review.
-
Addiction treatment in the postpartum period: an opportunity for evidence-based personalized medicine.Int Rev Psychiatry. 2021 Sep;33(6):579-590. doi: 10.1080/09540261.2021.1898349. Epub 2021 Jul 8. Int Rev Psychiatry. 2021. PMID: 34238101 Free PMC article. Review.
-
Postpartum and addiction recovery of women in opioid use disorder treatment: A qualitative study.Subst Abus. 2022;43(1):389-396. doi: 10.1080/08897077.2021.1944954. Epub 2021 Jul 2. Subst Abus. 2022. PMID: 34214405
-
Development of an unannounced standardized patient protocol to evaluate opioid use disorder treatment in pregnancy for American Indian and rural communities.Addict Sci Clin Pract. 2021 Jun 25;16(1):40. doi: 10.1186/s13722-021-00246-6. Addict Sci Clin Pract. 2021. PMID: 34172081 Free PMC article.
-
Outcomes associated with the use of medications for opioid use disorder during pregnancy.Addiction. 2021 Dec;116(12):3504-3514. doi: 10.1111/add.15582. Epub 2021 Jun 9. Addiction. 2021. PMID: 34033170